Compare QBTS & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QBTS | STXS |
|---|---|---|
| Founded | 1999 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | QBTS | STXS |
|---|---|---|
| Price | $25.09 | $2.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | ★ $31.50 | $4.00 |
| AVG Volume (30 Days) | ★ 30.3M | 404.4K |
| Earning Date | 11-06-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $24,144,000.00 | ★ $30,075,000.00 |
| Revenue This Year | $194.34 | $24.48 |
| Revenue Next Year | $56.23 | $29.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 156.20 | 19.62 |
| 52 Week Low | $3.74 | $1.54 |
| 52 Week High | $46.75 | $3.59 |
| Indicator | QBTS | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | 43.14 |
| Support Level | $23.82 | $2.31 |
| Resistance Level | $27.29 | $2.42 |
| Average True Range (ATR) | 2.44 | 0.09 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 46.81 | 46.37 |
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.